Consensus Generation Bio Co.

Equities

GBIO

US37148K1007

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
2.9 ^USD	-3.65%		+3.57%	+75.76%

Apr. 12	Transcript : Generation Bio Co. - Special Call
Mar. 07	Needham Cuts Price Target on Generation Bio to $10 From $14, Maintains Buy Rating	MT

Evolution of the average Target Price on Generation Bio Co.

Price target over the last 5 years

History of analyst recommendation changes

33c7d6ccaf52d7107c6fb12ec6c1.W3PF37zZlWLVOs08hYJZvuxVOsf5yp3mwG-QXI1LDXE.LUKN5tux_xS0ZalFvPcjjtUYD6Wc_siz8BzRO88pfEYyLIrn357hCKFTqg~26dee797440d5f0a31b796bb9fadedf7

Analyst Recommendations on Generation Bio Co.

Needham Cuts Price Target on Generation Bio to $10 From $14, Maintains Buy Rating	Mar. 07	MT
Wedbush Adjusts Generation Bio Price Target to $5 From $9, Maintains Outperform Rating	Nov. 29	MT
Wedbush Lowers Generation Bio's Price Target to $9 From $11, Maintains Outperform Rating	Nov. 10	MT
JMP Securities Downgrades Generation Bio to Market Perform From Market Outperform	23-10-23	MT
TD Cowen Downgrades Generation Bio to Market Perform From Outperform	23-10-19	MT
JPMorgan Chase Adjusts Price Target on Generation Bio to $9 From $8, Maintains Neutral Rating	23-08-16	MT
Wedbush Cuts Generation Bio's Price Target to $11 From $15, Maintains Outperform Rating	23-03-23	MT
Needham Adjusts Price Target on Generation Bio to $14 From $23, Maintains Buy Rating	23-02-24	MT
Wedbush Lowers Generation Bio's PT to $15 From $24, Pushes Out Launch Timings for Each Indication, Adjusts Capital Raise Assumptions; Keeps Outperform Rating	23-02-24	MT
JMP Securities Adjusts Price Target on Generation Bio to $7 From $11, Maintains Market Outperform Rating	23-01-19	MT
Canaccord Genuity Starts Generation Bio at Buy With $9 Price Target	22-11-08	MT
JMP Securities Adjusts Generation Bio's Price Target to $11 from $10, Keeps Market Outperform Rating	22-08-08	MT
Needham Adjusts Generation Bio's Price Target to $23 from $27, Keeps Buy Rating	22-08-05	MT
Wedbush Adjusts Price Target for Generation Bio to $24 From $23, Maintains Outperform Rating	22-06-21	MT
Wedbush Lowers Generation Bio's Price Target to $23 From $25, Citing Cost of Capital, Keeps Outperform Rating	22-05-06	MT
Wedbush Cuts Generation Bio's Price Target to $25 From $31, Citing Pipeline Timeline Adjustments, Keeps Outperform Rating	22-02-25	MT
Jefferies Adjusts Price Target for Generation Bio to $29 From $38, Maintains Buy Rating	21-12-15	MT
JMP Securities Adjusts Price Target on Generation Bio to $10 From $40, Maintains Market Outperform Rating	21-12-15	MT
Needham Adjusts Price Target on Generation Bio to $27 From $50, Maintains Buy Rating	21-12-15	MT
JPMorgan Downgrades Generation Bio to Neutral From Overweight, Sets $17 Price Target	21-12-14	MT
William Blair Downgrades Generation Bio to Market Perform From Outperform	21-12-14	MT
Wedbush Trims Generation Bio's Price Target to $31 From $36 on Hemophilia A Program Timeline; Outperform Rating Kept	21-12-14	MT
GENERATION BIO : Wedbush Adjusts Price Target on Generation Bio to $36 From $40 on Hemophilia A Program Timeline; Outperform Rating Kept	21-07-15	MT
GENERATION BIO : JMP Securities Starts Generation Bio at Market Outperform with $40 Price Target	21-06-08	MT
GENERATION BIO : JPMorgan Adjusts Generation Bio's Price Target to $39 From $34, Maintains Overweight Rating	21-03-22	MT